Search company, investor...

Lumo

lumo.tax

About Lumo

Lumo specializes in research and development (R&D) tax advisors. It works in close partnership with businesses, helping them understand and capitalize on R&D credits to both find and fund their futures. It serves the manufacturing, life sciences, software and technology, food and drink, and transport sectors. It was founded in 2016 and is based in Annfield Plain, England.

Headquarters Location

The Greenhouse Greencroft Industrial Park

Annfield Plain, England, DH9 7XN,

United Kingdom

Missing: Lumo's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Lumo's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Lumo News

LUMO Labs’ investment is via LUMO Fund II Coöperatieve U.A. LUMO Labs and Barmenia Next Strategies lead seed investment round in German startup Fimo Health - Lumo Labs

May 19, 2023

LUMO Labs and Barmenia Next Strategies lead seed investment round in German startup Fimo Health Press release June 8, 2022 Eindhoven, Netherlands – LUMO Labs’ pre-seed investment vehicle LUMO Fund Coöperatieve U.A. announces a seven-figure investment in Cologne-based German digital health startup that utilizes data science and technology to help patients cope with the symptoms of chronic diseases. Fimo Health is closing its first round of funding with LUMO Labs and Barmenia Next Strategies, the venture arm of German insurance company Barmenia, co-leading the capital raise. NRW.Bank and Rockstart are also investing. In early 2020, Benedict Höger, Alexander Krawinkel and Dominik Stiegeler founded Fimo Health as a symptom-management platform for chronic diseases with a focus on fatigue. Value proposition Fimo Health’s data-driven recommendations help patients better understand external influencing factors and leverage relevant knowledge from research and clinical practice to proactively counteract fatigue and other symptoms. “In various discussions with those affected, it has become clear to us how multifaceted fatigue is and how difficult the general symptom management is with chronic diseases,” said CEO Krawinkel. “With our app, we want to help those affected to precisely address these issues to improve the quality of life, but also to use the data in cooperation with doctors; for example, to enable the monitoring and improvement of therapies.” In two years, Fimo Health has developed programs for long Covid, multiple sclerosis and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in its CE-certified app and is the first certified medical device for the treatment of long Covid. Additional app versions incorporate content dealing with further symptoms or special features tailored to the specifics of the disease. “The app itself uses the smartphone, and different wearables can be connected to collect various vital and environmental parameters that can influence fatigue and other symptoms,” said Krawinkel. “In addition, the app collects further data via questionnaires and tests. With the help of our analysis of this data, patients can better understand their influencing factors and symptoms and proactively counteract them with the help of the program and tips and tricks.” The program covers various topics related to mindfulness, nutrition, exercise, energy and stress management and interaction with family and friends. More programs will follow during the year, e.g., in the oncology setting. Fimo Health’s technology not only empowers patients to use preventive measures, but it also aids insurance companies in reducing costs. Fimo Health already partners with several German public and private health insurers. “Fimo Health is the perfect example of how seemingly simple tools integrated in everyday devices can help relieve the impact of (semi-) chronic illness on patients and our healthcare system,” said Andy Lürling, LUMO Labs founding partner. “The Fimo Health ‘always on – always there’ mobile app allows patients to better understand the ‘why’ behind symptoms and flare-ups and provides actionable suggestions to prevent or minimize their impact.” “One of the distinctive qualities of Fimo Health’s founding team is their attention to the bigger picture,” said LUMO Labs Founding Partner Sven Bakkes. “They understand the value of their proposition lies not only in the quality of the tech, but just as much in having the right partnerships with multiple relevant stakeholders. “As such, we are delighted to co-invest alongside Barmenia Next Strategies, the Wuppertal-based venture arm of German insurance company Barmenia.” Fimo Health will use this investment to further expand its platform for fatigue and symptom management for chronic diseases. The team will use the next few months to become market leader in Germany, then expand abroad within two years. This is where LUMO Labs can provide great support to the Fimo team. Suggested Reading

Lumo Frequently Asked Questions (FAQ)

  • Where is Lumo's headquarters?

    Lumo's headquarters is located at The Greenhouse, Annfield Plain.

  • Who are Lumo's competitors?

    Competitors of Lumo include Arbo and 4 more.

Compare Lumo to Competitors

Synergi Partners Logo
Synergi Partners

Synergi Partners operates as an incentive and tax credit consulting and processing company. The company specializes in federal and state tax credit programs, disaster relief incentives, and more. It was founded in 2018 and is based in Florence, South Carolina.

Abingworth Logo
Abingworth

Abingworth is an international investment group focused exclusively on the life sciences and healthcare sectors. It was founded in 1973 and is based in London, England.

Tax Credit Co Logo
Tax Credit Co

Tax Credit Co. is a national provider of tax incentive consulting, administration and technology, serving clients from Fortune 100 to small business. The company helps clients increase earnings by optimizing the process of obtaining state and federal tax incentives, including state and federal research and development tax credits, state enterprise zone tax credits, national hiring incentives such as the Work Opportunity Tax Credit (WOTC) and other state and federal programs. Tax Credit Co.'s next-generation software platform manages national tax credit screening and compliance for large, complex organizations.

Q
Queen’s Lane Consultants

Queen’s Lane Consultants is a tax advisory firm. It assists with accounting, consulting, and credits. It was founded in 2018 and is based in London, United Kingdom.

M
Medilink UK

Medilink UK is a membership-based professional association and consulting firm that focuses on life science company growth. It uses the combined strengths of its regional partners to assist the growth and development of the life sciences commercial, academic, and clinical communities across the UK. It provides services to the medical device, pharmaceutical, and biotechnology industries. It was founded in 2005 and is based in Nottingham, United Kingdom.

A
Arbo

Arbo is an all-in-one financial planning and analysis (FP&A) software-as-a-service (SaaS) platform for technology companies. Its products include accounting, tax, CFO services, and R&D credit. It provides access to financial insights such as cash flow, burn rate, profitability, yearly taxes, and financial projections. The company was founded in 2018 and is based in Atlanta, Georgia.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.